Interestingly, a recent study demonstrated that decorin-coated titanium substrates abolished the oncogenic potential of osteosarcoma cells but, on the other hand, stimulated the proliferation of pre-osteoblasts [173], suggesting that decorin exerts specific antitumor action. The gene discussed is DCN; the disease is osteosarcoma.